262 39. Radi R, Peluffo G, Alvarex MN, Vaviliat M, Cayota A (2001) Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 30:463–488 40. Wilhelm SM, Simonson MS, Robinson AV, Stowe NT, Schulak JA (1999) Endothelin up regulation and localization following renal ischemia and reperfusion. Kidney Int 55:1011–1018 41. Ruschitzka F, Shaw S, Gygi D, Noll G, Barton M, Luscher TF (1999) Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1. J Am Soc Nephrol 10:953– 962 42. Forbes JH, Hewitson TD, Becker GJ, Jones CL (2001) Simulta- neous blockage of endothelin A and B receptors in ischemic acute renal failure is detrimental to long term kidney function. Kidney Int 59:1333–1341 43. Zuk A, Bonventre JV, Brown D, Matlin KS (1998) Polarity, integrin and extracellular matrix dynamics in the post ischemic rat kidney. Am J Physiol 275:C711–C731 44. Kwon O, Corrigan G, Meyers BD, Sibley R, Scandling JD, Dafoe D, Alfrey E, Nelson WJ (1999) Sodium reabsorption and distribution of Na+K+ATPase during post-ischemic injury to the renal allograft. Kidney Int 55:963–975 45. Van Why SK, Mann AS, Ardito T, Thulin G, Ferris S, Macleod MA, Kashgarin M, Siegel NJ (2002) Hsp27 associates with actin and limits injury in energy depleted renal epithelial. J Am Soc Nephrol 13:2667–2680 46. Luster AD (1998) Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445 47. Heinzelmann M, Mercer–Jones MA, Passmore JC (1999) Neu- trophils and renal failure. Am J Kidney Dis 34:384–399 48. Himmelfarb J, McMonagle E, Freedman S, Klenzak J, McMenamin E, Le P, Pupim LB, Ikizler TA, The PICARD Group (2004) Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 15:2449–2456 49. Basile DP, Donohoe D, Roethe K, Osborn JL (2001) Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term outcome. Am J Physiol 281: F887–F899 50. Zager RA (1996) Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 49:314–326 51. Andreoli SP, Clark JH, McGuire WA, Bergstein JM (1986) Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure. J Pediatr 109:292–298 52. Stapleton FB, Strother DR, Roy S, Wyatt RJ, McKay CP, Murphy SB (1988) Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma. Pediatrics 82:863–869 53. Jones DP, Mahmoud H, Chesney RW (1995) Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 9: 206–212 54. LaRosa C, McMullen L, Bakdash S, Ellis D, Krishnamurti L, Wu SY, Mortiz M (2007) Acute renal failure from xanthine nephropathy during management of acute leukemia. Pediatr Nephrol 22:132– 135 55. Rampello E, Tiziana F, Malaguarnera M (2006) The management of tumor lysis syndrome. Nat Clin Pract Oncol 3:438–447 56. Boles JM, Detel JL, Briere J, Mialon P, Robasckiewicz M, Garre M, Briere J (1984) Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of acute lymphoblastic leukemia. Cancer 53:2425–2494 57. Vohra S, Eddy A, Levin AV, Taylor G, Laxer RM (1999) Tubulointerstitial nephritis and uveitis in children and adolescents. Pediatr Nephrol 13:426–432 58. Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of shiga toxin associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 23:1749–1760 Pediatr Nephrol (2009) 24:253–263 59. Anochie I, Eke F (2005) Acute renal failure in Nigerian children: Port Harcourt experience. Pediatr Nephrol 20:1610–1614 60. Olowu WA, Adelusola KA (2004) Pediatric acute renal failure in southwestern Nigeria. Kidney Int 66:1541–1548 61. Jenik AG, Ceriani Cernadas JM, Gorenstein A, Ramirez JA, Vain N, Armadans M, Ferraris JR (2000) A randomized, double blind, placebo controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia. Pediatrics 105:849–853 62. Bakr AF (2005) Prophylactic theophylline to prevent renal dysfunction in term newborns exposed to perinatal asphyxia—a study in a developing country. Pediatr Nephrol 20:1249–1253 63. Bhat M, Shah Z, Makidoomi MS, Mufti MH (2006) Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo controlled trial. J Pediatr 149:180–183 64. Cantarovich F, Rangoonwala, B, Loremz H, Verho M, Esnault VL, High-Dose Furosemide in Acute Renal Failure Study Group (2004) High dose furosemide for established ARF: a prospective, randomized, double blind, placebo controlled, multicenter trial. Am J Kidney Dis 44:402–409 65. Kellum JA (1998) Use of diuretics in the acute care setting. Kidney Int 1998 53:67–70 66. Mehta R, Pascaul MT, Soroko S, Chertow GM (2002) Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288:2547–2553 67. Bellomo R, Chapman M, Finfer S, Hicklling K, Myburgh J (2000) Low dose dopamine in patients with early renal dysfunction: a placebo controlled randomised trial. Lancet 356:2139–2143 68. Kellum JA, Decker JM (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526 69. Lauschke A, Teichgraber UKM, Frei U, Eckardt KU (2006) “Low-dose” dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 69:1669–1674 70. Marik PE (2002) Low-dose dopamine: a systemic review. Intensive Care Med 28:877–883 71. Friedrich JO, Adhikari N, Herridge MS, Beyene J (2005) Meta- analysis: low dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Int Med 142:510–524 72. Marthur VS, Swan SK, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epstein M, Luther RR (1999) The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 27:1832–1837 73. Landoni G, Biondi-Zoccai GGL, Tumlin JA (2007) Beneficial Impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 49:56–68 74. Knoderer CA, Leiser JD, Nailescu C, Turrentine MW, Andreoli SP (2008) Fenoldopam for acute kidney injury in children. Pediatr Nephrol 23:495–498 75. Kohda Y, Chiao H, Starr RA (1998) A melanocyte stimulating hormone protects against renal injury after ischemia in mice and rats. Curr Opin Nephrol Hypertens 99:1165–1172 76. Weston CE, Feibelman MB, Wu K, Simon EE (1999) Effect of oxidant stress on growth factor stimulation of proliferation in cultured human proximal tubular cells. Kidney Int 56:1274–1276 77. Chatterjee PK, Cuzzocreas S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C (2000) Tempol, a membrane permeable radical scavenger reduces oxidant stress mediated renal dysfunction and injury in the rat. Kidney Int 58:658–673 78. Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C (2005) Administered mesenchymal stem cells enhance recovery from ischemic/reperfusion-induced acute renal failure in rats. Kidney Int 68:1613–1617 79. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD,